230 related articles for article (PubMed ID: 22857536)
1. Bismuth compounds in medicinal chemistry.
Salvador JA; Figueiredo SA; Pinto RM; Silvestre SM
Future Med Chem; 2012 Jul; 4(11):1495-523. PubMed ID: 22857536
[TBL] [Abstract][Full Text] [Related]
2. Specific interactions of Bi(III) with the Cys-Xaa-Cys unit of a peptide sequence.
Rowinska-Zyrek M; Valensin D; Szyrwiel L; Grzonka Z; Kozlowski H
Dalton Trans; 2009 Nov; (42):9131-40. PubMed ID: 20449188
[TBL] [Abstract][Full Text] [Related]
3. Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kumar I
Chem Commun (Camb); 2013 Apr; 49(28):2870-2. PubMed ID: 23450139
[TBL] [Abstract][Full Text] [Related]
4. Bismuth coordination networks containing deferiprone: synthesis, characterisation, stability and antibacterial activity.
Burrows AD; Jurcic M; Mahon MF; Pierrat S; Roffe GW; Windle HJ; Spencer J
Dalton Trans; 2015 Aug; 44(31):13814-7. PubMed ID: 26172618
[TBL] [Abstract][Full Text] [Related]
5. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
[TBL] [Abstract][Full Text] [Related]
6. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
Shaikh AR; Giridhar R; Megraud F; Yadav MR
Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
[TBL] [Abstract][Full Text] [Related]
7. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.
Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; MacLellan JG; Vom A
Dalton Trans; 2012 Oct; 41(38):11798-806. PubMed ID: 22903621
[TBL] [Abstract][Full Text] [Related]
8. Bismuth(III) complexes derived from α-amino acids: the impact of hydrolysis and oxido-cluster formation on their activity against Helicobacter pylori.
Busse M; Border E; Junk PC; Ferrero RL; Andrews PC
Dalton Trans; 2014 Dec; 43(48):17980-90. PubMed ID: 25310996
[TBL] [Abstract][Full Text] [Related]
9. Homo- and heteroleptic bismuth(III/V) thiolates from N-heterocyclic thiones: synthesis, structure and anti-microbial activity.
Luqman A; Blair VL; Brammananth R; Crellin PK; Coppel RL; Andrews PC
Chemistry; 2014 Oct; 20(44):14362-77. PubMed ID: 25224757
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
Jada S; Doma MR; Singh PP; Kumar S; Malik F; Sharma A; Khan IA; Qazi GN; Kumar HM
Eur J Med Chem; 2012 May; 51():35-41. PubMed ID: 22424614
[TBL] [Abstract][Full Text] [Related]
11. Porphyrin complexes of the period 6 main group and late transition metals.
Lemon CM; Brothers PJ; Boitrel B
Dalton Trans; 2011 Jul; 40(25):6591-609. PubMed ID: 21384031
[TBL] [Abstract][Full Text] [Related]
12. Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.
Kowalik M; Masternak J; Barszcz B
Curr Med Chem; 2019; 26(4):729-759. PubMed ID: 28971764
[TBL] [Abstract][Full Text] [Related]
13. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis((4)N-methylthiosemicarbazone): crystal structure and both in vitro and in vivo biological evaluation.
Li MX; Yang M; Niu JY; Zhang LZ; Xie SQ
Inorg Chem; 2012 Nov; 51(22):12521-6. PubMed ID: 23136979
[TBL] [Abstract][Full Text] [Related]
14. Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes.
Ferraz KS; Silva NF; da Silva JG; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Mendes IC; Beraldo H
Eur J Med Chem; 2012 Jul; 53():98-106. PubMed ID: 22520151
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex.
Zhu Y; Chen Y; Li Q; Zhao T; Zhang M; Feng W; Takase M; Wu X; Zhou Z; Yang L; Wu X
Carbohydr Polym; 2014 Sep; 110():231-7. PubMed ID: 24906751
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Activities of Organotin(IV) Complexes as Antitumoral and Antimicrobial Agents. A Review.
Shah SS; Ashfaq M; Waseem A; Ahmed MM; Najam T; Shaheen S; Rivera G
Mini Rev Med Chem; 2015; 15(5):406-26. PubMed ID: 25910654
[TBL] [Abstract][Full Text] [Related]
17. Beyond catalysis: N-heterocyclic carbene complexes as components for medicinal, luminescent, and functional materials applications.
Mercs L; Albrecht M
Chem Soc Rev; 2010 Jun; 39(6):1903-12. PubMed ID: 20502793
[TBL] [Abstract][Full Text] [Related]
18. One dodecahedral bismuth(III) complex derived from 2-acetylpyridine N(4)-pyridylthiosemicarbazone: synthesis, crystal structure and biological evaluation.
Li M; Lu Y; Yang M; Li Y; Zhang L; Xie S
Dalton Trans; 2012 Nov; 41(41):12882-7. PubMed ID: 22986888
[TBL] [Abstract][Full Text] [Related]
19. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
